Pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH) are not popular topics of media coverage and popular conversation in the way that cancer and heart disease are. Despite increasing numbers of people diagnosed with PH/PAH worldwide, pulmonary hypertension has been a historically neglected disease. Which is a bit puzzling, since…
Search results for:
Social Clips
Riociguat Clinical Trials for Pulmonary Hypertension
In this webcast shared by the American College of Cardiology, we find out more about the use of riociguat for the treatment of pulmonary hypertension (PH). Â Two-year study of riociguat as CTEPH treatment identifies predictive disease markers.
In this video from West Park Health Centre, Dr. Roger Goldstein explains the importance of pulmonary rehabilitation for people with chronic lung diseases such as pulmonary hypertension (PH) and COPD. MORE:Â Discover four ways the American Lung Association help patients manage their lung disease. Dr.
This podcast series, created and produced by phaware, is being offered as a regular guest feature on Pulmonary Hypertension News to bring the voices and life experiences of PH patients, family members, caregivers, healthcare specialists, and others to our readers. You may listen to…
Pulmonary hypertension (PH) is a rare but severe health condition characterized by high blood pressure in the blood vessels that transport blood from the heart to the lungs. In PH, the pulmonary arteries become narrowed and stiff, making it more difficult for blood to pass through them. As a…
The World Health Organization has a pulmonary hypertension clinical classification system that was created in 2008 and updated the following year, where they divide the disease into five groups, sorted by cause, origin, incidence and prevalence. This classification system is used for death certificates, diagnosis, mortality statistics, records, and other purposes. MORE: …
This podcast series, created and produced by phaware, is being offered as a regular guest feature on Pulmonary Hypertension News to bring the voices and life experiences of PH patients, family members, caregivers, healthcare specialists, and others to our readers. You may listen to the podcast directly, or read it…
Treatment with the approved therapy Uptravi (selexipag) safely reduces disease severity and improves heart and lung health in people with pulmonary hypertension (PH), according to a review study. Researchers recommended that Uptravi be considered for use in patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic…
[vc_row][vc_column][vc_column_text]Pulmonary hypertension (PH) is a severe disease diagnosed when the arteries responsible for transporting blood from the heart to the lungs become constricted. Under normal circumstances, blood is supposed to gather oxygen from the lungs and distribute it to the organs, muscles and body tissue. However, due to the disease, normal blood flow…
Pulmonary hypertension (PH) is a rare, life-threatening disease that occurs because of high blood pressure in the arteries of the lungs. The disease requires urgent medical intervention and lifestyle changes. When first diagnosed, patients and their family members and caregivers may have unanswered questions. Many want to know how…